XML 50 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
Detail of Certain Accounts (Tables)
9 Months Ended
Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Cash and Cash Equivalents
Amounts related to Quanta’s cash and cash equivalents based on geographic location of the bank accounts were as follows (in thousands):
 September 30, 2022December 31, 2021
Cash and cash equivalents held in domestic bank accounts$175,846 $205,781 
Cash and cash equivalents held in foreign bank accounts39,549 23,316 
Total cash and cash equivalents$215,395 $229,097 
Amounts related to cash and cash equivalents held by
consolidated or proportionately consolidated joint ventures and the captive insurance company, which are included in Quanta’s total cash and cash equivalents balances, were as follows (in thousands):
 September 30, 2022December 31, 2021
Cash and cash equivalents held by domestic joint ventures$18,712 $21,828 
Cash and cash equivalents held by foreign joint ventures5,087 3,461 
Total cash and cash equivalents held by joint ventures23,799 25,289 
Cash and cash equivalents held by captive insurance company46,539 133,302 
Cash and cash equivalents not held by joint ventures or captive insurance company145,057 70,506 
Total cash and cash equivalents$215,395 $229,097 
Accounts Payable and Accrued Expenses
Accounts payable and accrued expenses consisted of the following (in thousands):
 September 30, 2022December 31, 2021
Accounts payable, trade$1,383,079 $1,251,118 
Accrued compensation and related expenses597,235 547,161 
Other accrued expenses429,286 456,392 
Accounts payable and accrued expenses$2,409,600 $2,254,671